伊戈爾(002922.SZ):因英威解散清 其持有的2072.17萬股已登記至英威公司的股東名下
格隆匯11月25日丨伊戈爾(002922.SZ)公佈,公司於2019年11月25日收到公司股東貴州英威企業管理有限公司(“英威”)出具的《關於英威完成證券非交易過户的告知函》,因英威解散清算,其持有的伊戈爾首次公開發行前股份2072.17萬股(佔公司總股本的15.40%)已通過證券非交易過户的方式登記至英威公司的股東名下,相關手續已辦理完畢,英威公司已於2019年11月22日取得中國證券登記結算有限責任公司深圳分公司出具的《證券過户登記確認書》。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.